Arm rose 2.6% Saudi sovereign wealth fund PIF opened a new position in the first quarter and bought Arm call options

Gelonghui May 16 | Chip company Arm (ARM.US) rose 2.6% to US$116.63

Gelonghui, May 16 | Chip company Arm (ARM.US) rose 2.6% to US$116.63.
On the news, Saudi Arabia’s sovereign wealth fund PIF disclosed its first-quarter positions. It bought a large number of new Arm call options. The position has ranked as the seventh largest position.

Like (0)
Previous May 16, 2024 11:25 pm
Next May 16, 2024 11:25 pm

Related posts

  • Teradyne rose more than 8% before the market opened, and its Q2 performance guidance exceeded expectations.

    .app-kaihu-qr{text-align: center;padding: 20px 0;}.app-kaihu-qr span{font-size: 18px; line-height: 31px;display: block;}.app-kaihu-qr img{width: 170px;height: 170px;display: block;margin: 0 auto;margin-top: 10px;}The stock market is picking up, open an account first to buy stocks at the bottom! Smart fixed investment, conditional orders, individual stock radar…given to you>> .appendQr_wrap{border:1px solid #E6E6E6;padding:8px;} .appendQr_normal{float:left;} .appendQr_normal img{width:74px;} .appendQr_normal_txt{ float:left;font-size:20px;line-height:74px;padding-left:20px;color:#333;} Massive information and accurate interpretation, all in Sina Finance APP Editor-in-Chief: Guo Mingyu

    US stock market April 25, 2024
  • Olin Biotechnology (688319.SH): Net loss in the first quarter was 25.9969 million yuan

    Gelonghui April 25丨Olin Biotechnology (688319.SH) announced the first quarter report of 2024. During the reporting period, the company achieved revenue of 70.8 million yuan, a year-on-year increase of 5.87%; net profit loss attributable to the parent company was 25.9969 million yuan; excluding non-profit Net profit loss was 27.84 million yuan. Basic earnings per share -0.0641 yuan.

    US stock market April 25, 2024
  • Nordisk fell 1.1% in premarket as the U.S. Senate launches investigation into Novo Nordisk\’s GLP-1 drug pricing

    Gelonghui, April 25 | Nord Nordisk (NVO.US) U.S. stocks fell 1.1% before the market opened, to US$124.74. On the news, U.S. Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders said on Wednesday that the committee is launching an investigation into Novo Nordisk\’s pricing. In a letter sent to Novo Nordisk\’s CEO on Wednesday, Sanders asked Novo Nordisk to provide \”internal communications about the U.S. pricing of the drug\” and explain why Ozempic and Wegovy have the same ingredient (semaglutide). ), Wegovy’s pricing is obviously more expensive. Sanders stressed that the price of GLP-1 drugs \”must come down\” so that consumers can afford them and the government doesn\’t go bankrupt by reimbursing them.

    US stock market April 25, 2024
  • Gift Nifty signals flat-to-positive opening; low participation expected

    As we approach the weekend, domestic markets are anticipated to open flat on Friday. It’s worth noting that market participation is expected to remain low, primarily due to the long weekend holidays. This is because the market will be closed on Monday for local polling related to the general election, a factor that could influence trading volumes and market dynamics.

    US stock market May 17, 2024
  • Central Shopping Mall (600280.SH): Net profit in the first quarter was 6.2257 million yuan

    Gelonghui April 25 | Central Shopping Mall (600280.SH) released its first quarter report for 2024. During the reporting period, the company\’s operating income was 633 million yuan, a year-on-year decrease of 0.71%; the net profit attributable to shareholders of the listed company was 6.2257 million yuan; The net profit after deducting non-recurring gains and losses for shareholders of listed companies is 6.8092 million yuan; basic earnings per share is 0.006 yuan per share.

    US stock market April 25, 2024
  • Polestar failed to submit its annual report on time, Nasdaq issued a violation notice

    Polestar announced on May 17 that due to the failure to submit its annual report as of December 31, 2023, the company received a notice from Nasdaq confirming that the company did not comply with the provisions of the Nasdaq listing rules. requires the timely filing of all required periodic financial reports with the Securities and Exchange Commission

    US stock market May 19, 2024